NCT00695435

Tobramycin Tear Concentrations

Evaluation of Tobramycin Tear Concentrations of TOBRADEX® Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension Versus TOBREX® Ophthalmic Solution in Normal Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To evaluate the Tobramycin tear concentration values of TOBRADEX® Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension versus TOBREX® Ophthalmic Solution in normal volunteers.

Conditions

• Dry Eye

Interventions

Type	Name	Description
DRUG	TOBRADEX Ophthalmic Suspension	TOBRADEX Ophthalmic Suspension 1 drop each eye at baseline
DRUG	Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension	Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension 1 drop each eye at baseline
DRUG	TOBREX Ophthalmic Solution	TOBREX Ophthalmic Solution 1 drop each eye at baseline

Timeline

• Start date: 2008-06-01
• Primary completion: 2008-06-01
• First posted: 2008-06-11
• Last updated: 2010-03-02
• Results posted: 2010-02-05

Locations

1 site across 1 country: United States